Double-masked Controlled Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease
Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This is a phase 2, multi-center, double-masked, randomized, vehicle-controlled,
dose-response, parallel-group study designed to evaluate the safety and tolerability and
ocular efficacy of SY-201 Ophthalmic Solution versus vehicle over a 60-day treatment period
in subjects with dry eye disease (DED).